NASDAQ:AVLN | Free Cash Flow | Avalyn Pharma Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2025-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$29.89M$318,000.00-$30.21M
2025-03-31-$19.28M$8,000.00-$19.28M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income